Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults

March 17, 2015 updated by: Case Comprehensive Cancer Center

RATIONALE: Learning about young adults' knowledge and perceptions about risk factors for the human papilloma virus and cervical cancer may help doctors learn more about how to prevent human papilloma virus infection and cervical cancer in the future.

PURPOSE: This clinical trial is studying knowledge and perceptions of the risk factors for human papilloma virus infection and cervical cancer in young adults.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

OBJECTIVES:

  • Describe the socio-demographic context of college students in an urban Midwestern setting.
  • Assess knowledge of the human papillomavirus (HPV) and cervical cancer in these participants.
  • Assess the population's perception of HPV risk.
  • Assess the prevalence of risk behaviors that may place this population at risk for HPV.
  • Identify the best predictors of HPV knowledge and cervical cancer knowledge.
  • Assess vaccine knowledge and acceptance in these participants.

OUTLINE: Participants complete the Young Adult Survey online documenting demographic data; sexual history (i.e., whether they ever had sex, age of first sexual encounter, number of life time partners, condom use, sexually transmitted diseases [STDs], and pregnancy history); cigarette use; current and past drug use; knowledge of human papillomavirus (HPV) and cervical cancer; past history of Pap tests and STD screenings; attitudes towards HPV testing; vaccine knowledge and acceptability; sources of information about HPV; source of information about cervical cancer; identification of common STDs; perceived risk of acquiring STDs; perceived risk of acquiring HPV; social support; and religion.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Ohio
      • Cleveland, Ohio, United States, 44106-5065
        • Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
      • Cleveland, Ohio, United States, 44024
        • Geauga Regional Hospital
      • Cleveland, Ohio, United States, 44060
        • Lake/University Ireland Cancer Center
      • Cleveland, Ohio, United States, 44121
        • University Suburban Health Center
      • Cleveland, Ohio, United States, 44122
        • UHHS Chagrin Highlands Medical Center
      • Cleveland, Ohio, United States, 44130
        • Southwest General Health Center
      • Cleveland, Ohio, United States, 44145
        • UHHS Westlake Medical Center
      • Cleveland, Ohio, United States, 44708
        • Mercy Cancer Center at Mercy Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 24 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Community based outreach in an urban Mid-west area

Description

DISEASE CHARACTERISTICS:

  • Currently enrolled in a college, university, or community college in the Greater Cleveland metropolitan area
  • Currently single and never married

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Socio-demographic context of college students in an urban Midwestern setting
Knowledge of human papillomavirus (HPV) and cervical cancer
Perception of HPV risk
Prevalence of risk behaviors that may place this population at risk for HPV
Best predictors of HPV knowledge and cervical cancer knowledge
Vaccine knowledge and acceptance

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Case Comprehensive Cancer Center

Collaborators

National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Shelley A. Francis, PhD, MPH, CHES, Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2008

Primary Completion (ACTUAL)

July 1, 2009

Study Registration Dates

First Submitted

August 14, 2008

First Submitted That Met QC Criteria

August 14, 2008

First Posted (ESTIMATE)

August 15, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

March 19, 2015

Last Update Submitted That Met QC Criteria

March 17, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CASE11806 (OTHER: Case Comprehensive Cancer Center)
  • P30CA043703 (U.S. NIH Grant/Contract)
  • CASE-11806-CC231

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe